Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung CancerPei‐Chih Lee, Mien‐Chie Hung, Hirohito Yamaguchi et al.|Cancer Cell|2018Cited by 71
Recent Advances in Nanomedicine: Cutting-Edge Research on Nano-PROTAC Delivery Systems for Cancer TherapyXiaoqing Wu, Zhengyu Zha|Pharmaceutics|2025Cited by 16